no weight loss with tirzepatide obesity trial non-diabetic pros and cons for A 72-week compared the two leading GLP-1 medications in adults (no diabetes). The Tirzepatide outcompetes long-acting insulin in – Is Tirzepatide Safe For Long-Term

The peptide appears to engage several key pathways simultaneously

The consistency and magnitude of tirzepatide's effect across diverse patient populations has made it the preferred choice for accelerated weight loss outcomes

The GI side effects from both compounds are manageable for most people, but they can be severe enough to require dose reduction or treatment discontinuation in a meaningful minority

But even as semaglutide keeps evolving, researchers are studying newer medications that may push weight-loss results even further

Dietary modifications can help reduce gastrointestinal side effects that may contribute to poor sleep

Large-scale trials, including cardiovascular outcome studies, have not reported a significant rise in heart failure incidents among tirzepatide users